CyberKnife arrives in Abu Dhabi with precision cancer care in its sights

Abu Dhabi just planted another flag in its fast-growing medical frontier. Tawam Hospital, under SEHA and the wider PureHealth family, has unveiled its first CyberKnife S7 system. This quiet but powerful arrival sets a new benchmark for cancer treatment in the UAE. It is the first time CyberKnife is being used in Abu Dhabi. It signals a healthcare system that is neither waiting nor following but leading from the front.

As Dr Noura Khamis Al Ghaithi put it, the emirate is pushing for "world-class healthcare" that harnesses science and innovation to save lives. Her words feel like the opening line of a new chapter for the region.

How does it work?

CyberKnife does not slice or cut. Instead, it treats tumours with radiation so precise it feels like threading a needle in a storm.
Think of it as a robotic sharpshooter for cancer cells.
It works like this:

• Targets tumour sites with high-dose radiation
• Tracks movement in real time to avoid harming healthy tissue
• Removes the need for surgical cuts and long recovery
• Handles tumours in places where a scalpel may struggle

Tawam Hospital reports that 23 people have already been treated. One was the first prostate cancer case to be handled with CyberKnife in the facility. Twelve were brain tumours. Seven were prostate cancers. Others included bone cancer, head tumours, and complex cases normally considered risky.

Rashed Al Qubaisi from PureHealth called the rollout "a powerful example of PureHealth's commitment to redefining the future of healthcare." His sentiment feels well placed. Precision medicine is no longer conceptual here. It is already working, patient by patient.

Why does it matter?

For patients, it means hope with less pain. For doctors, accuracy is sharper than ever. And for Abu Dhabi, it is a significant step toward global leadership in cancer care.

CyberKnife signals three important shifts:

• More treatment without surgery
• Fewer side effects and shorter recovery times
• Access to advanced, evidence-based care inside the UAE

This treatment saves tissue while targeting the disease. Treatment that lets people return to their lives faster. Saeed Jaber Al Kuwaiti, Group CEO of SEHA, summed it up clearly. "This milestone reflects our unwavering commitment to delivering personalised, high precision care that puts the patient first." That line alone tells you where this story is heading.

The context

PureHealth has been steadily building a healthcare ecosystem known for scale and ambition. The CyberKnife S7 is now the most advanced unit of its kind in the UAE. It treats cancers of the brain, spine, liver, lung, pancreas, and prostate. It also extends beyond oncology into disorders such as trigeminal neuralgia and vascular malformations.

In other words, this is no single-use instrument. It is a doorway to modern cancer care, the kind that draws global talent and raises outcomes across populations.

Abu Dhabi is not only adopting new medicine. It is setting the pace. And with CyberKnife now operating at Tawam Hospital, cancer treatment in the region will never be the same again.